Skip to content
OpenCapital
Get started

Esperion Therapeutics ESPR Market capitalization

Market capitalization at other companies

Amgen logo
AmgenAMGN
$189.67B+13.3%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
NewAmsterdam Pharma Company logo
NewAmsterdam Pharma CompanyNAMS
$3.68B+63.7%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$660.94M+297%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$673.38M+93.4%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$547.19M+35.0%

Other financials

Income statement

See full
Revenue$80.1M+23.2%
Operating income-$6.6M+70.2%
Net income-$25.2M+37.7%
EPS (diluted)-$0.10+52.4%

Balance sheet

See full
Cash & equivalents$156.2M+36.2%
Total debt$155.2M+6.1%
Total equity-$307.9M+27.8%
Total assets$462.5M+42.7%

Cash flow

See full
Operating cash flow-$27.7M-22.5%
CapEx$189.0K—
Free cash flow-$27.9M-23.3%

Valuation

See full
Enterprise value$810.81M+233%
P/S1.9×+1.1×

Profitability

See full
Operating margin18.1%+12.7pp
Net margin-34.8%+8.0pp
FCF margin-30.7%—

Returns & leverage

See full
Return on equity-260.8%—
Debt / equity0.8×—
Current ratio1.5×+0.4×

Where this comes from

Computed from the period-end share price: $703.66M.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Esperion Therapeutics's market capitalization?
Esperion Therapeutics (ESPR) reported market capitalization of $703.66M in Q1 2026.
How has Esperion Therapeutics's market capitalization changed year-over-year?
Esperion Therapeutics's market capitalization increased by 147.0% year-over-year, from $284.9M to $703.66M.
What is the long-term trend for Esperion Therapeutics's market capitalization?
Over 5 years (2020 to 2025), Esperion Therapeutics's market capitalization has grown at a -11.5% compound annual growth rate (CAGR), from $1.62B to $877.16M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.